Accelerating the development of therapeutic strategies for drug-resistant tuberculosis

Michael J Vjecha; Simon Tiberi; Alimuddin Zumla

doi:10.1038/nrd.2018.28

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis

Nat Rev Drug Discov. 2018 Sep;17(9):607-608. doi: 10.1038/nrd.2018.28. Epub 2018 Mar 23.

Authors

Michael J Vjecha¹, Simon Tiberi², Alimuddin Zumla^{3

4}

Affiliations

¹ Veterans Affairs Medical Center, Washington, DC, USA.
² Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
³ Division of Infection and Immunity, University College London, London, UK.
⁴ NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.

PMID: 29567994
DOI: 10.1038/nrd.2018.28

Abstract

Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in tuberculosis treatment.

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural